Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
TP53 deficiency
Description:
TP53 deficiency is impaired or absent function of the TP53 tumor-suppressor gene, studied in cancer biology and its effects on tumor development and treatment.
Related topics:
Cancer-related Molecular Pathways (17%),
PARP inhibition in cancer therapy (12%),
Chronic Lymphocytic Leukemia Research (8%)
OpenAlex ID:
keywords/tp53-deficiency
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53 - and RB1 -deficient prostate cancer
2017
·
Ping Mu
, Zeda Zhang
, et al.
·
Science
·
1,172
ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cells
2015
·
Marwan Kwok
, Nicholas Davies
, et al.
·
Blood
·
304
Activating Notch1 mutations in mouse models of T-ALL
2005
·
Jennifer O'Neil
, Jennifer Calvo
, et al.
·
Blood
·
261
Small Interfering RNA Screens Reveal Enhanced Cisplatin Cytotoxicity in Tumor Cells Having both BRCA Network and TP53 Disruptions
2006
·
Steven R. Bartz
, Zhan Zhang
, et al.
·
Molecular and Cellular Biology
·
195
DNA damage response pathway in radioadaptive response
2002
·
Masao S. Sasaki
, Yosuke Ejima
, et al.
·
Mutation research. Fundamental and molecular mechanisms of mutagenesis
·
177
Single-cell genomic variation induced by mutational processes in cancer
2022
·
Tyler Funnell
, Ciara H. O’Flanagan
, et al.
·
Nature
·
167
PDF
Vulnerabilities of PTEN – TP53 -Deficient Prostate Cancers to Compound PARP–PI3K Inhibition
2014
·
Enrique González-Billalabeitia
, Nina Seitzer
, et al.
·
Cancer Discovery
·
101
PDF
Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer
2021
·
Sebastian M. Dieter
, Christine Siegl
, et al.
·
Cell Reports
·
99
PDF
Immune checkpoint B7-H3 is a therapeutic vulnerability in prostate cancer harboring PTEN and TP53 deficiencies
2023
·
Wei Shi
, Yin Wang
, et al.
·
Science Translational Medicine
·
95
PDF
Synthetic lethality in chronic lymphocytic leukaemia with DNA damage response defects by targeting the ATR pathway
2015
·
Marwan Kwok
, Nicholas Davies
, et al.
·
The Lancet
·
89
Identification of CDC25 as a Common Therapeutic Target for Triple-Negative Breast Cancer
2018
·
Jeff C. Liu
, Letizia Granieri
, et al.
·
Cell Reports
·
85
PDF
Exosomal micro RNA s derived from colon cancer cells promote tumor progression by suppressing fibroblast TP 53 expression
2019
·
Shunsuke Yoshii
, Yoshito Hayashi
, et al.
·
Cancer Science
·
83
PDF
tp53 deficiency causes a wide tumor spectrum and increases embryonal rhabdomyosarcoma metastasis in zebrafish
2018
·
Myron S Ignatius
, Madeline N Hayes
, et al.
·
eLife
·
80
Bcl-2 Inhibitor ABT-199 (GDC-0199) Monotherapy Shows Anti-Tumor Activity Including Complete Remissions In High-Risk Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)
2013
·
Matthew S. Davids
, John M. Pagel
, et al.
·
Blood
·
79
Co-targeting hexokinase 2-mediated Warburg effect and ULK1-dependent autophagy suppresses tumor growth of PTEN- and TP53- deficiency-driven castration-resistant prostate cancer
2016
·
Lei Wang
, Ji Wang
, et al.
·
EBioMedicine
·
69
PDF
Nanoformulation of Olaparib Amplifies PARP Inhibition and Sensitizes PTEN/TP53- Deficient Prostate Cancer to Radiation
2017
·
Anne L. van de Ven
, Shifalika Tangutoori
, et al.
·
Molecular Cancer Therapeutics
·
66
Replication-induced DNA damage after PARP inhibition causes G 2 delay, and cell line-dependent apoptosis, necrosis and multinucleation
2015
·
Idun Dale Rein
, Kirsti Solberg Landsverk
, et al.
·
Cell Cycle
·
62
PDF
A P53-Deficiency Gene Signature Predicts Recurrence Risk of Patients with Early-Stage Lung Adenocarcinoma
2018
·
Yanding Zhao
, Frederick S. Varn
, et al.
·
Cancer Epidemiology Biomarkers & Prevention
·
61
G 2 /M-Phase Arrest and Death by Apoptosis of HL60 Cells Irradiated with Exponentially Decreasing Low-Dose-Rate Gamma Radiation
1999
·
Shoucheng Ning
, Susan J. Knox
·
Radiation Research
·
61
Synthetic Cannabinoids Induce Autophagy and Mitochondrial Apoptotic Pathways in Human Glioblastoma Cells Independently of Deficiency in TP53 or PTEN Tumor Suppressors
2021
·
Aleksandra Ellert-Miklaszewska
, Iwona Anna Ciechomska
, et al.
·
Cancers
·
60
PDF
Deficient TP53 Expression, Function, and Cisplatin Sensitivity Are Restored by Quinacrine in Head and Neck Cancer
2007
·
Jay Friedman
, Liesl Nottingham
, et al.
·
Clinical Cancer Research
·
60
AXL Inhibition Induces DNA Damage and Replication Stress in Non–Small Cell Lung Cancer Cells and Promotes Sensitivity to ATR Inhibitors
2021
·
Kavya Ramkumar
, C. Allison Stewart
, et al.
·
Molecular Cancer Research
·
59
Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia
2017
·
Gero Knittel
, Tim Rehkämper
, et al.
·
Nature Communications
·
59
PDF
Immunosurveillance against tetraploidization-induced colon tumorigenesis
2013
·
Alice Boilève
, Laura Senovilla
, et al.
·
Cell Cycle
·
50
PDF
Extracellular vesicles and PD-L1 suppress macrophages, inducing therapy resistance in TP53-deficient B-cell malignancies
2022
·
Elena Izquierdo
, Daniela Vorholt
, et al.
·
Blood
·
48
PDF
Show more works
View as search
Works count:
205
Citation count:
4,304
Year
Topic
Type